Treatment of Chronic Itch in Patients Under Arsenic Exposure With Sublingual Naloxone
Condition:   Chronic Pruritus Interventions:   Drug: Naloxone;   Drug: Desloratadine Sponsor:   Xiangya Hospital of Central South University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2018 Category: Research Source Type: clinical trials

Desloratadine,Phenylephrine Hcl,Ibuprofen Compared to Placebo in Treatment of Symptoms Associated With Common Cold/Flu
Condition:   Cold Interventions:   Drug: Desloratadine+Phenylephrine+Ibuprofen;   Drug: Placebo Sponsor:   Ache Laboratorios Farmaceuticos S.A. Not yet recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 8, 2016 Category: Research Source Type: clinical trials

Aprepitant vs. Desloratadine in EGFR-TKIs Related Pruritus Treatment
Condition:   Non-small Cell Lung CancerInterventions:   Drug: Aprepitant and placebo;   Drug: desloratadine and placeboSponsor:   Sun Yat-sen UniversityActive, not recruiting - verified January 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 10, 2015 Category: Research Source Type: clinical trials

Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)
Condition:   Seasonal Allergic RhinitisInterventions:   Drug: Desloratadine 5 mg;   Drug: PlaceboSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2014 Category: Research Source Type: clinical trials

Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)
Condition:   Seasonal Allergic RhinitisInterventions:   Drug: Desloratadine 5 mg;   Drug: PlaceboSponsor:   Merck Sharp & Dohme Corp.Recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2014 Category: Research Source Type: clinical trials

Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)
Condition:   Seasonal Allergic RhinitisInterventions:   Drug: Desloratadine 5 mg;   Drug: PlaceboSponsor:   Merck Sharp & Dohme Corp.Active, not recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2014 Category: Research Source Type: clinical trials

Efficacy and Safety Study of Desloratadine (MK-4117) in Japanese Participants With Seasonal Allergic Rhinitis (MK-4117-204)
Condition:   Seasonal Allergic RhinitisInterventions:   Drug: Desloratadine 5 mg;   Drug: PlaceboSponsor:   Merck Sharp & Dohme Corp.Completed - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2014 Category: Research Source Type: clinical trials

Anti-histamines and Methacholine Challenges.
Condition:   AsthmaInterventions:   Drug: Diphenhydramine;   Drug: cetirizine;   Drug: desloratadine;   Drug: placeboSponsor:   Don CockcroftCompleted - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 31, 2013 Category: Research Source Type: clinical trials

A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)
Condition:   Perennial Allergic RhinitisInterventions:   Drug: Desloratadine 5 mg;   Drug: PlaceboSponsor:   Merck Sharp & Dohme Corp.Completed - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 5, 2013 Category: Research Source Type: clinical trials

A Study of the Efficacy and Safety of Desloratadine (MK-4117) in Japanese Participants With Perennial Allergic Rhinitis (MK-4117-200)
Condition:   Perennial Allergic RhinitisInterventions:   Drug: Desloratadine 5 mg;   Drug: PlaceboSponsor:   Merck Sharp & Dohme Corp.Completed - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 5, 2013 Category: Research Source Type: clinical trials